Verge Labs
PrivateLast Round
Strategic
Sep 8, 2023
Est. Valuation
$1.71M
Total Funding Raised
$134.12M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Verge Labs is a biotechnology company that provides drug developers with an AI-powered platform and proprietary patient genomic datasets to identify therapeutic targets for neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Verge Labs Comparables
Compare Verge Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 1910 Genetics | 82% | |
| AcuraStem | 82% | |
| Argo Therapeutics | 81% |
Verge Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 8, 2023 | ||||
| Series B | Dec 16, 2021 | ||||
| Strategic | Jul 8, 2021 | ||||
| Series A | Jul 16, 2018 | ||||
| Seed | Oct 28, 2015 | ||||
Accelerator | Jul 21, 2015 |
Verge Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Slow Ventures | Seed |
| S32 | Series B |
| Agent Capital | Series A |
| Great Oaks Venture Capital | Seed |
| Threshold Ventures | Series B |
| DFJ Ventures | Series A |
| Lifeforce Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Eli Lilly and AstraZeneca partnerships exceed $1.6B.
- Feb 23, 2026
Two unnamed drugs have been delivered to the clinic.
Verge Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Verge Labs's valuation, stock price, and market status.
Is Verge Labs a public or private company?
Verge Labs is a private company.
What is the current stock price of Verge Labs?
Verge Labs is a private company, so its shares have no public market price. Caplight tracks Verge Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Verge Labs worth (valuation)?
Verge Labs's valuation is estimated at $1.7M based on funding round data.
Can I buy Verge Labs stock?
Verge Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Verge Labs's last funding round?
Verge Labs's most recent funding round was Strategic on September 8, 2023.
Who are the main investors in Verge Labs?
Key investors in Verge Labs include Great Oaks Venture Capital, DFJ Ventures, Two Sigma Ventures, IA Ventures, Draper Fisher Jurvetson Management.
Will Verge Labs IPO soon?
No public IPO plans have been announced for Verge Labs.
How can I track Verge Labs secondary market activity?
Caplight tracks bids, offers, and trades in Verge Labs's shares on secondary markets.